
Cannabotech Ltd. (CNTC.TA)
CNTC.TA Stock Price Chart
Explore Cannabotech Ltd. interactive price chart. Choose custom timeframes to analyze CNTC.TA price movements and trends.
CNTC.TA Company Profile
Discover essential business fundamentals and corporate details for Cannabotech Ltd. (CNTC.TA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
26 Jul 2021
Employees
6.00
Website
https://cannabotech.comCEO
Elchanan Shaked
Description
CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products. It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products. The company is based in Rishon LeZion, Israel.
CNTC.TA Financial Timeline
Browse a chronological timeline of Cannabotech Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 10 Feb 2025
Stock split effective on 21 Jan 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Feb 2024
EPS came in at -ILA 30.00 , while revenue for the quarter reached ILA 645.00K .
Earnings released on 29 Jun 2023
EPS came in at -ILA 39.66 , while revenue for the quarter reached ILA 574.00K .
Earnings released on 29 Jun 2022
EPS came in at -ILA 85.07 , while revenue for the quarter reached ILA 448.00K .
Earnings released on 30 Dec 2021
EPS came in at -ILA 105.46 , while revenue for the quarter reached ILA 153.00K .
Earnings released on 29 Jun 2021
EPS came in at -ILA 94.34 .
Earnings released on 30 Dec 2020
EPS came in at -ILA 46.08 .
CNTC.TA Stock Performance
Access detailed CNTC.TA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.